Both in Pharmaceuticals
Precigen vs SELLAS Life Sciences Group
Over the past year PGEN returned +71.4% and SLS returned +406.8%; their daily moves had a correlation of 0.23.
PGEN +71.4% SLS +406.8%Growth of $1, one year, split-adjusted
| Metric | PGEN | SLS |
|---|---|---|
| Price | $6.94 | $9.68 |
| Market cap | $2.48B | $1.95B |
| Today | +4.52% | −4.68% |
| 1 month | −15.5% | −14.6% |
| 6 months | +70.1% | +96.3% |
| Year to date | +66.0% | +156.8% |
| 1 year | +73.1% | +365.4% |
| Revenue growth (YoY) | +6322.7% | — |
| Gross margin | 94.9% | — |
| Net margin | 36.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 29.0× | — |
| Net cash | -$55.7M | $138.3M |
| Dividend yield | — | — |
| Volatility (60d) | 62.3% | 94.9% |
| Short % of float | 26.1% | 27.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).